​Our partners include:

UNESCO:

​The "Guidelines on Traditional Pharmacopoeia in the Context of Sport Values, Ethics, and Integrity" document, developed by Prof. Aburjai as the head of the Pilot Regional Taskforce of the Arab region, addresses the use of traditional herbal medicine in sports, emphasizing the need for regulation to maintain sports ethics and integrity. The guidelines arose from the increased use of herbal medicine during the COVID-19 pandemic and aim to protect athletes from the potential doping effects of certain herbs. The document outlines the historical and cultural significance of traditional medicine in the Arab world and acknowledges its continued relevance. It identifies key challenges, including safety, quality control, and the lack of regulatory frameworks. The taskforce, composed of regional experts, emphasizes the importance of creating a digital platform for knowledge exchange and education on the subject. This platform, supported by UNESCO, aims to foster collaboration among experts and provide resources for both athletes and the general public. The guidelines also highlight the need for further research and the development of national policies to integrate traditional medicine into healthcare systems, ensuring its safe and ethical use in sports.​

WADA (World anti-doping agency):

Prof. Aburjai participated in preparing the international standard prohibited list as a part of the world anti-doping code.

Advanced Pharma Care:

Our research group is excited to collaborate with Advanced Pharma Care​s to bridge the gap between fundamental natural products research and its practical application in the pharmaceutical industry. By combining our expertise in identifying and characterizing bioactive compounds from natural sources with Advanced Pharma Care​​'s industry knowledge, we aim to develop innovative and effective pharmaceutical and nutraceutical products.

​Itqan Pharma: 

Our research group is excited to announce a new collaboration with Itqan Pharma, a leading pharmaceutical company. This partnership leverages our expertise in natural products research and Itqan Pharma's advanced capabilities in drug development. Together, we aim to explore and develop innovative, naturally-derived therapeutic agents that address unmet medical needs. This collaboration represents a significant step forward in our mission to translate natural products research into effective, sustainable healthcare solutions.​

Philipps-Universität Marburg:

a DAAD funded project 2023-2025, entitled: Evaluation of Medicinal Plants of the Near and Middle East and their Benefits for National Health Systems (MediPlant): The Near and Middle East are rich in medicinal plants, with Asian floral elements being added Mediterranean flora. In the literature of the beginning of the 20th century, the area of Lebanon, Jordan and Syria are considered to be one floral space. Iraq is the outer most east border of the area with very special habitats in the north and along the rivers. For all four countries, close to 3.000 vascular plants are currently described. Numerous species are used in traditional medicine. The plant genera Allium with 28 species, Euphorbia with 36 species and Thymus with 2 species are striking here. One of the best-known species with traditional use are Rheum ribes (Syrian rhubarb, currant-fruited rhubarb, warty-leaved rhubarb) and Salvia species; here there are indications that a remedy against corona infections can be developed from the plant extract; the other plant genes listed above also have antiviral activity. However, the diversity of the species and their place of growth are endangered. There is a risk that the ongoing reshaping of natural biotopes will wipe out valuable species and with them also the orally transmitted knowledge of traditional use. Therefore, cultivation of most important plants is urgently required. In this second project phase, distinct medicinal plants of the region should be analysed in detailed and pharmaceutical formulation should be prepared out of them. Also, safety of common herbal drugs should be evaluated as well as their importance to the national health systems. For distinct medicinal plants, possibilities for cultivation should be evaluated.

The aims of the network project are:

- Evaluation of potential medicinal plants of the region their medicinal use,

- Development of concepts for phytotherapy as a contribution to national health systems,

- Evaluation of possibilities for cultivation,

- Joined investigation of distinct plants,

- Exchange of staff and improved teaching programme.

DAAD PIANO project 2021-2023:

The aims of this project could be summarize in the following points 1. In Jordan, more than 2,000 vascular plants are currently described. Numerous species are used in traditional medicine. The plant genera Allium with 28 species, Euphorbia with 36 species and Thymus with 2 species are striking here. One of the best-known species with traditional use is Rheum ribes (Syrian rhubarb, currantfruited rhubarb, warty-leaved rhubarb); here there are indications that a remedy against corona infections can be developed from the plant extract, the other plant genes listed above also have antiviral activity. 2. Many plant species and their place of growth are endangered. There is a risk that the ongoing reshaping of natural biotopes will wipe out valuable species and with them also the orally transmitted knowledge of traditional use. So this project aiming at starting ethnopharmacological studies regarding these plants and finding a way to protect them. 3. Development of the concept of "Pharmaceutical Biology according to international criteria. 4. Cultivation of medicinal plants, processing and marketing strategies shoüld be taken under consideration. 5. Special concern will be mad on some Jordanian plants which may have good potential as herbal medicines for treatment of some chronic diseases.​ 6. Teaching aids are to be made available for the project, for example for creating an herbarium and for internet-based teaching. 7. The project will offer full cover fellowship for post graduate Jordanian students (MSc or PhD) for the period of 1-3 months in Marburg, Germany. Please note the followings: This project is fully covered financially from the DAAD. Arny financial support for purchasing materials needed or instrument will be done via the DAAD directly No direct money transfers for the researchers or their institution is available No financial incentives are available for the researchers.​

​​

​